SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (14695)9/17/2000 10:13:25 AM
From: manfredhasler  Read Replies (3) of 17367
 
George, Re: in the U.K. there has been a massive p.r. campaign for years to get parents to recognize the signs of meningococcemia

Interesting to know. Let's try to benefit from that. We can both check as soon as the details of the study can be reviewed:

The investigators point out the possible deleterious effect of the 6 hour (logistic) delay for the study drug administration on the study outcome. If this is not only excuse they might provide some data to support that. At least they might have some data in hand for a retrospective analysis: if the PR campaign in the UK yielded any benefit the study results might support such a notion. The working hypothesis would be: if more screened children form the UK (compared to the US) finally got the study medication this could be because more US children had a delay (for the study medication to be given) due to the innocence of their parents.

(My guess for the records: the authors do not address this question).

We will see.

Regards,
Manfred

BTW: I am very sceptical about a possible benefit of (prospective) parental education in meningococcemia. On the other side, I am much less sceptical in stressing the importance of proper execution to the medical profession.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext